Browse COVID-19 resources from partners and CCSA experts – trusted sources for your information and research needs.

Canadian Centre on Substance Use and Addiction

Implications of COVID-19 Webinar Series

The COVID-19 pandemic has had far-reaching impacts on public health in Canada, including substance use and access to healthcare services and supports.


CCSA’s new webinar series explores the implications of COVID-19 on public health, highlighting work in the area of substance use and COVID-19 across sectors and across the country. You can expect to hear a variety of perspectives from leading experts spanning topics from harm reduction, stigma, domestic violence, adverse childhood events and youth.

Be sure to bookmark this page for updates to our webinar schedule and to view recordings of past webinars.

Spaces for each webinar are limited so register early to secure your place.

Rapid Access to Addiction Medicine and Withdrawal Options

Date: August 11, 2020, 1 p.m. – 2 p.m., EST

Addiction... haunted by stigma, harms, and trauma. This webinar will explore underlying issues with substance use disorders and help attendees to understand their complexity and treatment from an evidence-based lens. A focus on the impacts of COVID, withdrawal considerations and advancements in delivery of care during these uncertain times, including the Rapid Access to Addiction Medicine model.

Speaker: Dr. Ginette Poulin, Clinical Lead, Canadian Research Initiative in Substance Misuse

Please note that this webinar will be presented in English.

Register now

The Effects of COVID-19 on the Illegal Drug Supply

Date: August 17, 2020, 1 p.m. – 2:30 p.m., EST

This webinar will explore how regulations put in place to prevent the spread of COVID-19 are inadvertently contributing to an increasingly toxic illegal drug supply and how this shift has both increased health harms and created policy opportunities. Presentations will highlight different perspectives, including systems-level epidemiology data, findings from a local drug checking program and experiences shared by people who use drugs.


  • Dr. Jane Buxton, Physician Epidemiologist and Harm Reduction Lead, BC Centre for Disease Control

    Dr. Jane Buxton is a public health physician and professor in the School of Population and Public Health at the University of British Columbia. She is the medical lead for harm reduction at the BC Centre for Disease Control, where in 2011 she developed the inter-sectoral Drug Overdose and Alert Partnership to identify and respond to provincial issues related to illegal drugs. In 2012, she led the implementation of the take home naloxone program in British Columba, which has recorded over 63,000 overdose reversals, and introduced an annual harm reduction client survey. Jane uses quantitative and qualitative approaches in her research and is committed to including the authentic voices of the experts — people with lived and living experience of substance use — in developing policy, program planning, research and evaluation.

  • Karen McDonald, Operations Manager, Centre on Drug Policy Evaluation

    Karen is Operations Manager at the Centre on Drug Policy Evaluation, which is in St. Michael's Hospital in Toronto, Ontario. Karen oversees Toronto’s drug checking service — a multi-site pilot project that collects samples at five of the city’s frontline harm reduction agencies and analyzes them at two clinical laboratories using mass spectrometry. Karen brings over ten years of public sector experience during which she has contributed to health policy and systems change. She holds a Master of Public Policy, Administration and Law from York University.

  • Matthew Bonn, Safe Supply and Drug Policy Consultant, Canadian Association of People who Use Drugs

Please note that this webinar will be presented in English.

Register now

We use cookies to ensure that we give you the best experience possible on our website. 

You can change your cookie settings in your web browser at any time. If you continue without changing your settings, we’ll assume that you are happy to receive cookies from our website. Review our Privacy Notice for more information.